Skip to main content
Log in

Prodrugs of 5-Iodo-2′-Deoxyuridine for Enhanced Ocular Transport

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Problems associated with the use of 5-iodo-2′-deoxyundine (IDU) in the treatment of herpes simplex keratitis can be attributed largely to the polar nature of IDU resulting in its poor permeability across the lipoidal epithelial layer of the corneal membrane. Five aliphatic 5′-esters of IDU were synthesized and evaluated as prodrugs for potential use in the treatment of deep ocular infections such as stromal keratitis, iritis, and even retinitis. A parabolic relationship between in vitro corneal membrane permeability and carbon chain length of prodrugs is evident. For a given prodrug, enzymatic hydrolysis proceeded most readily in iris–ciliary body, followed by cornea and aqueous humor. An increase in carbon chain length made the prodrugs more enzymatically labile but more resistant to chemical hydrolysis at pH 7.4 and 34°C. The 5′-butyryl ester of IDU exhibited an approximately fourfold increase in aqueous humor IDU concentration relative to IDU at 25 min following instillation of 25-µl 5 mM solutions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Physicians' Desk Reference for Ophthalmology, Medical Economics, N.J., 1987, pp. 96, 151.

  2. M. M. Narurkar and A. K. Mitra. Pharm. Res. 5:734–737 (1988).

    Google Scholar 

  3. A. K. Mitra and T. J. Mikkelson. J. Pharm. Sci. 77:771–775 (1988).

    Google Scholar 

  4. R. D. Schoenwald and H. S. Huang. J. Pharm. Sci. 72:1266–1271 (1983).

    Google Scholar 

  5. G. L. Mosher and T. J. Mikkelson. Int. J. Pharm. 2:239–243 (1979).

    Google Scholar 

  6. G. L. Flynn and S. H. Yalkowsky. J. Pharm. Sci. 61:838–853 (1972).

    Google Scholar 

  7. G. M. Grass and J. R. Robinson. J. Pharm. Sci. 77:3–14 (1988).

    Google Scholar 

  8. V. H. L. Lee, R. E. Stratford, Jr., and K. W. Morimoto. Int. J. Pharm. 13:183–195 (1983).

    Google Scholar 

  9. V. H. L. Lee. J. Pharm. Sci. 72:239–244 (1983).

    Google Scholar 

  10. R. S. Holmes and C. J. Masters. Biochim. Biophys. Acta 132:379–381 (1967).

    Google Scholar 

  11. N. D. Das and H. Shichi. Exp. Eye Res. 33:525–528 (1981).

    Google Scholar 

  12. M. Dixon and E. C. Webb. Enzymes, 3rd ed., Academic Press, New York, 1979, pp. 231–270.

    Google Scholar 

  13. B. H. J. Hofstee. J. Biol. Chem. 207:219–222 (1956).

    Google Scholar 

  14. V. H. L. Lee, S. C. Chang, C. M. Oshiro, and R. E. Smith. Curr. Eye Res. 4:1117–1125 (1985).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Narurkar, M.M., Mitra, A.K. Prodrugs of 5-Iodo-2′-Deoxyuridine for Enhanced Ocular Transport. Pharm Res 6, 887–891 (1989). https://doi.org/10.1023/A:1015968724007

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015968724007

Navigation